Discounted Cash Flow Rating
Neutral
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Neutral
Price to Earnings Rating
Strong Sell
Analyst Rating
Sell
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Neutral
Standard Deviation
Sell
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Neutral
B
Ovid Therapeutics Inc. Common Stock (OVID)
Pharmaceutical Preparations
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class or best-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
441 NINTH AVENUE, 14TH FLOOR
NEW YORK, NY
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
05/05/2017
Market Cap
78,068,760
Shares Outstanding
70,680,000
Weighted SO
70,680,551
Total Employees
N/A
Upcoming Earnings
08/02/2024
Beta
0.4340
Last Div
0.0000
Range
0.68-4.139
Chg
-0.0300
Avg Vol
935232
Mkt Cap
78068760
Exch
NASDAQ
Country
US
Phone
646 661 7661
DCF Diff
1.4055
DCF
-0.3055
Div Yield
0.0000
P/S
137.5579
EV Multiple
-0.9653
P/FV
0.8775
Div Yield %
0.0000
P/E
-2.6223
PEG
1.9143
Payout
0.0000
Current Ratio
5.7291
Quick Ratio
5.7291
Cash Ratio
2.1031
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
-15.9257
CCC
15.9257
Gross Margin
191.6100
Op Margin
-120.0830
Pretax Margin
-52.4152
Net Margin
-52.4152
Eff Tax Rate
-0.0031
ROA
-0.2519
ROE
-0.3340
ROCE
-0.6555
NI/EBT
1.0000
EBT/EBIT
0.4365
EBIT/Rev
-120.0830
Debt Ratio
0.0192
D/E
0.0255
LT Debt/Cap
0.0108
Total Debt/Cap
0.0248
Int Coverage
-0.0444
CF/Debt
-23.3780
Equity Multi
1.3283
Rec Turnover
0.0000
Pay Turnover
-22.9190
Inv Turnover
0.0000
FA Turnover
0.0406
Asset Turnover
0.0048
OCF/Share
-0.7460
FCF/Share
-0.7468
Cash/Share
1.0854
OCF/Sales
-93.2179
FCF/OCF
1.0011
CF Coverage
-23.3780
ST Coverage
-40.9793
CapEx Coverage
-889.7313
Div&CapEx Cov
-889.7313
P/BV
0.8775
P/B
0.8775
P/S
137.5579
P/E
-2.6223
P/FCF
-1.4740
P/OCF
-1.4745
P/CF
-1.4745
PEG
1.9143
P/S
137.5579
EV Multiple
-0.9653
P/FV
0.8775
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
2.36M Shares Bought (99.61 %)
9.18K Shares Sold (0.39%)
3 - 6 Months
360.00K Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
6 - 9 Months
455.00K Shares Bought (35.11 %)
840.77K Shares Sold (64.89%)
9 - 12 Months
18.25K Shares Bought (99.99 %)
0.00 Shares Sold (0.01 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | ▲ 5.70M | ▼ -416.35M | ▲ 46.28K | ▲ 141.56K | ▲ 148.00K |
Cost Of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 439.95K | ▼ 401.39K | ▼ 136.00K |
Gross Profit | 0.00 | 0.00 | ▲ 5.70M | ▼ -416.35M | ▲ -393.67K | ▲ -259.83K | ▲ 12.00K |
Gross Profit Ratio | 0.00 | 0.00 | ▲ 1.00 | 1.00 | ▼ -8.51 | ▲ -1.84 | ▲ 0.08 |
Research And Development Expenses | 8.62M | ▲ 12.11M | ▲ 16.88M | ▲ 18.09M | ▼ 5.55M | ▲ 10.54M | ▼ 10.30M |
General And Administrative Expenses | 4.50M | ▲ 5.16M | ▲ 10.41M | ▼ 8.26M | ▼ 6.67M | ▲ 7.69M | ▼ 7.17M |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -301.00K | ▲ -35.00K |
Selling General And Administrative Expenses | 4.50M | ▲ 5.16M | ▲ 10.41M | ▼ 8.26M | ▼ 6.67M | ▲ 7.39M | ▼ 7.13M |
Other Expenses | 0.00 | 0.00 | ▼ -438.26K | ▲ 3.90K | ▲ 668.12K | ▼ -4.08M | ▲ 5.72M |
Operating Expenses | 13.13M | ▲ 17.27M | ▲ 27.29M | ▼ 26.35M | ▼ 12.22M | ▲ 17.93M | ▼ 17.43M |
Cost And Expenses | 13.13M | ▲ 17.27M | ▲ 27.29M | ▼ 26.35M | ▼ 12.22M | ▲ 18.33M | ▼ 17.57M |
Interest Income | 226.36K | ▲ 298.72K | ▼ -854.79K | ▲ 0.00 | ▲ 668.12K | ▼ 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -1.06M | ▲ 1.54B | ▼ 0.00 |
Depreciation And Amortization | 55.29K | ▼ 53.80K | ▲ 83.04K | ▼ 56.95K | ▲ 439.95K | ▼ 401.39K | ▼ 136.00K |
Ebitda | -13.13M | ▼ -17.27M | ▼ -21.59M | ▼ -26.30M | ▲ -12.17M | ▼ -17.79M | ▲ -17.28M |
Ebitda Ratio | 0.00 | 0.00 | ▼ -3.79 | ▲ 0.06 | ▼ -100.00 | -100.00 | -100.00 |
Operating Income | -13.13M | ▼ -17.27M | ▼ -27.29M | ▲ -26.35M | ▲ -12.17M | ▼ -18.19M | ▲ -17.42M |
Operating Income Ratio | 0.00 | 0.00 | ▼ -4.79 | ▲ 0.06 | ▼ -263.02 | ▲ -128.48 | ▲ -117.68 |
Total Other Income Expenses Net | 226.08K | ▲ 298.55K | ▼ -438.26K | ▲ 3.90K | ▲ 668.12K | ▲ 2.87M | ▲ 5.72M |
Income Before Tax | -12.90M | ▼ -16.97M | ▼ -22.03M | ▼ -26.35M | ▲ -11.50M | ▼ -15.32M | ▲ -11.69M |
Income Before Tax Ratio | 0.00 | 0.00 | ▼ -3.86 | ▲ 0.06 | ▼ -100.00 | -100.00 | ▲ -79.01 |
Income Tax Expense | -846.00 | ▲ -231.00 | ▲ 258.00 | ▼ -349.71K | ▲ -50.00K | ▲ -2.00 | ▲ 0.00 |
Net Income | -12.90M | ▼ -16.97M | ▼ -22.03M | ▼ -26.00M | ▲ -11.45M | ▼ -15.32M | ▲ -11.69M |
Net Income Ratio | 0.00 | 0.00 | ▼ -3.86 | ▲ 0.06 | ▼ -100.00 | -100.00 | ▲ -79.01 |
Eps | -0.52 | ▲ -0.35 | ▲ -0.34 | ▼ -0.38 | ▲ -0.16 | ▼ -0.22 | ▲ -0.17 |
Eps Diluted | -0.52 | ▲ -0.35 | ▲ -0.34 | ▼ -0.38 | ▲ -0.16 | ▼ -0.22 | ▲ -0.17 |
Weighted Average Shs Out | 24.64M | ▲ 49.14M | ▲ 62.95M | ▲ 67.51M | ▲ 70.47M | ▲ 70.69M | ▲ 70.72M |
Weighted Average Shs Out Dil | 24.64M | ▲ 49.14M | ▲ 64.00M | ▲ 68.16M | ▲ 70.47M | ▲ 70.69M | ▲ 70.72M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 36.49M | ▲ 41.90M | ▲ 72.03M | ▲ 187.80M | ▼ 129.00M | ▼ 27.04M | ▲ 30.77M |
Short Term Investments | 5.01M | ▲ 34.84M | ▼ 0.00 | 0.00 | ▲ 84.13M | ▼ 78.79M | ▼ 59.49M |
Cash And Short Term Investments | 41.50M | ▲ 76.74M | ▼ 72.03M | ▲ 187.80M | ▼ 129.00M | ▼ 105.83M | ▼ 90.26M |
Net Receivables | 0.00 | ▲ 1.13M | ▼ 141.76K | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Current Assets | 2.77M | ▼ 1.94M | ▲ 2.67M | ▲ 2.68M | ▼ 2.38M | ▲ 3.76M | ▼ 2.91M |
Total Current Assets | 44.27M | ▲ 79.81M | ▼ 74.84M | ▲ 190.48M | ▼ 131.38M | ▼ 109.60M | ▼ 93.17M |
Property Plant Equipment Net | 69.87K | ▼ 68.36K | ▲ 135.62K | ▲ 242.76K | ▲ 16.07M | ▼ 14.66M | ▼ 14.31M |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -39.09K | ▲ 0.00 | 0.00 |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 261.19K | ▼ 182.97K | ▼ 0.00 |
Goodwill And Intangible Assets | 391.87K | ▲ 467.00K | ▼ 319.00K | ▼ 164.09K | ▲ 222.10K | ▼ 182.97K | ▼ 0.00 |
Long Term Investments | 0.00 | 0.00 | 0.00 | ▲ 1.63M | ▲ 5.62M | ▲ 19.56M | ▲ 23.95M |
Tax Assets | 0.00 | 0.00 | 0.00 | ▲ 96.03K | ▼ 0.00 | ▼ -1.00 | ▲ 0.00 |
Other Non Current Assets | 2.92M | ▼ 495.18K | ▲ 627.80K | ▲ 1.93M | ▲ 1.97M | ▼ 26.60K | ▲ 176.00K |
Total Non Current Assets | 3.38M | ▼ 1.03M | ▲ 1.08M | ▲ 4.07M | ▲ 23.89M | ▲ 34.43M | ▲ 38.44M |
Other Assets | 0.00 | 0.00 | ▼ -100.00 | ▲ 0.00 | 0.00 | ▲ 1.00 | ▼ 0.00 |
Total Assets | 47.65M | ▲ 80.84M | ▼ 75.93M | ▲ 194.54M | ▼ 155.27M | ▼ 144.03M | ▼ 131.61M |
Account Payables | 3.76M | ▼ 3.26M | ▲ 5.45M | ▲ 7.13M | ▼ 1.95M | ▲ 3.70M | ▼ 3.60M |
Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 533.95K | ▲ 1.25M | ▲ 1.27M |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Revenue | 0.00 | 0.00 | ▲ 2.21M | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Other Current Liabilities | 5.09M | ▲ 7.28M | ▲ 14.40M | ▼ 7.67M | ▼ 4.50M | ▲ 6.53M | ▼ 4.04M |
Total Current Liabilities | 8.84M | ▲ 10.53M | ▲ 22.06M | ▼ 14.80M | ▼ 6.99M | ▲ 11.47M | ▼ 8.90M |
Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 16.00M | ▲ 30.00M | 30.00M |
Deferred Revenue Non Current | 0.00 | 0.00 | ▲ 10.17M | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Liabilities Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Liabilities | 0.00 | ▲ 286.56K | ▼ 61.20K | ▲ 7.13M | ▼ 0.00 | ▲ 14.76M | ▼ 14.43M |
Total Non Current Liabilities | 0.00 | ▲ 286.56K | ▲ 10.23M | ▼ 7.13M | ▲ 16.00M | ▲ 44.76M | ▼ 44.43M |
Other Liabilities | 0.00 | 0.00 | 0.00 | ▼ -7.13M | ▲ 0.00 | 0.00 | 0.00 |
Capital Lease Obligations | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 16.54M | ▼ 14.76M | ▼ 14.43M |
Total Liabilities | 8.84M | ▲ 10.82M | ▲ 32.29M | ▼ 14.80M | ▲ 22.99M | ▲ 56.23M | ▼ 53.33M |
Preferred Stock | 0.00 | ▲ 8.00 | ▼ 3.00 | ▼ 1.00 | 1.00 | 1.00 | ▼ 0.00 |
Common Stock | 24.65K | ▲ 54.71K | ▲ 65.74K | ▲ 70.36K | ▲ 70.47K | ▲ 70.69K | ▲ 71.00K |
Retained Earnings | -152.70M | ▼ -213.16M | ▼ -294.19M | ▲ -171.36M | ▼ -225.53M | ▼ -277.87M | ▼ -289.56M |
Accumulated Other Comprehensive Income Loss | -1.83K | ▲ 2.47K | ▼ 0.00 | ▼ -1.00 | ▼ -42.19K | ▲ 702.00 | ▼ -19.00K |
Other Total Stockholders Equity | 191.56M | ▲ 283.12M | ▲ 337.76M | ▲ 351.03M | ▲ 357.77M | ▲ 365.59M | ▲ 367.79M |
Total Stockholders Equity | 38.81M | ▲ 70.02M | ▼ 43.63M | ▲ 179.75M | ▼ 132.27M | ▼ 87.80M | ▼ 78.28M |
Total Equity | 38.81M | ▲ 70.02M | ▼ 43.63M | ▲ 179.75M | ▼ 132.27M | ▼ 87.80M | ▼ 78.28M |
Total Liabilities And Stockholders Equity | 47.65M | ▲ 80.84M | ▼ 75.93M | ▲ 194.54M | ▼ 155.27M | ▼ 144.03M | ▼ 131.61M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 47.65M | ▲ 80.84M | ▼ 75.93M | ▲ 194.54M | ▼ 155.27M | ▼ 144.03M | ▼ 131.61M |
Total Investments | 5.01M | ▲ 34.84M | ▼ 0.00 | ▲ 1.63M | ▲ 89.76M | ▲ 98.35M | ▼ 83.44M |
Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 16.54M | ▲ 46.00M | ▼ 45.70M |
Net Debt | -36.49M | ▼ -41.90M | ▼ -72.03M | ▼ -187.80M | ▲ -112.47M | ▲ 18.96M | ▼ 14.93M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -12.90M | ▼ -16.97M | ▼ -22.03M | ▼ -26.00M | ▲ -11.50M | ▼ -15.32M | ▲ -11.69M |
Depreciation And Amortization | 55.29K | ▼ 53.80K | ▲ 83.04K | ▼ 56.95K | ▲ 439.95K | ▼ 401.39K | ▼ 136.00K |
Deferred Income Tax | 4.61K | ▼ 0.00 | ▼ -21.62B | ▲ 0.00 | 0.00 | ▼ -105.41K | ▲ 0.00 |
Stock Based Compensation | 1.73M | ▼ 1.13M | ▲ 2.05M | ▼ 1.32M | ▲ 1.73M | ▲ 1.79M | ▲ 1.97M |
Change In Working Capital | 120.55K | ▼ -1.06M | ▲ 5.39M | ▼ 5.33M | ▼ -66.15K | ▲ 3.65M | ▼ -1.74M |
Accounts Receivables | 0.00 | 0.00 | ▲ 989.38K | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Inventory | 0.00 | 0.00 | ▲ 2.56M | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payables | -863.88K | ▼ -2.11M | ▲ 2.54M | ▲ 3.99M | ▼ 919.84K | ▲ 2.49M | ▼ -107.00K |
Other Working Capital | 984.44K | ▲ 1.05M | ▼ -703.19K | ▲ 1.34M | ▼ -985.99K | ▲ 1.17M | ▼ -1.63M |
Other Non Cash Items | 22.71K | ▼ -42.50K | ▲ 21.62B | ▼ 7.30M | ▼ 225.64K | ▼ -2.33M | ▼ -3.01M |
Net Cash Provided By Operating Activities | -10.97M | ▼ -16.89M | ▲ -14.51M | ▲ -12.00M | ▲ -9.18M | ▼ -11.91M | ▼ -16.69M |
Investments In Property Plant And Equipment | -21.43K | ▼ -211.87K | ▲ -90.48K | ▼ -161.96K | ▲ -63.00K | ▲ -1.22K | ▼ -19.00K |
Acquisitions Net | 27.05K | ▼ -5.00B | ▲ 9.95B | ▼ 48.10K | ▲ 2.50M | ▲ 48.50M | ▼ 0.00 |
Purchases Of Investments | -36.52K | ▼ -34.80M | ▼ -9.95B | ▲ -1.63M | ▼ -64.11M | ▲ -58.51M | ▲ -9.79M |
Sales Maturities Of Investments | 17.00M | ▲ 5.00B | ▼ -45.00M | ▲ 1.59M | ▲ 60.00M | ▼ 10.00M | ▲ 30.00M |
Other Investing Activities | -27.05K | ▲ 0.00 | ▲ 45.00M | ▼ -3.77K | ▼ -2.50M | ▼ -48.50M | ▲ 20.21M |
Net Cash Used For Investing Activities | 16.94M | ▼ -35.01M | ▲ -90.48K | ▼ -161.96K | ▼ -4.17M | ▼ -48.52M | ▲ 20.19M |
Debt Repayment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -30.00M | ▲ 0.00 |
Common Stock Issued | 0.00 | ▲ 55.89M | ▼ -221.07K | ▲ 0.00 | ▲ 180.66M | ▼ 33.39K | ▲ 228.00K |
Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -43.60K | ▼ -15.45B | ▲ 0.00 |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 2.00 | ▼ 0.00 | ▼ -11.42K | ▲ 109.18K | ▼ -180.66M | ▲ 30.03M | ▼ 228.00K |
Net Cash Used Provided By Financing Activities | 2.00 | ▲ 55.89M | ▼ -232.48K | ▲ 109.18K | ▼ -43.60K | ▲ 30.03M | ▼ 228.00K |
Effect Of Forex Changes On Cash | 0.00 | 0.00 | 0.00 | ▼ -129.62M | ▲ 0.00 | ▼ -15.44B | ▲ 0.00 |
Net Change In Cash | 5.98M | ▼ 3.99M | ▼ -14.83M | ▲ -12.05M | ▼ -13.39M | ▼ -30.40M | ▲ 3.73M |
Cash At End Of Period | 36.49M | ▲ 41.90M | ▲ 72.03M | ▲ 189.73M | ▼ 46.80M | ▼ 27.04M | ▲ 30.77M |
Cash At Beginning Of Period | 30.51M | ▲ 37.91M | ▲ 86.87M | ▲ 201.78M | ▼ 60.19M | ▼ 57.44M | ▼ 27.04M |
Operating Cash Flow | -10.97M | ▼ -16.89M | ▲ -14.51M | ▲ -12.00M | ▲ -9.18M | ▼ -11.91M | ▼ -16.69M |
Capital Expenditure | -21.43K | ▼ -211.87K | ▲ -90.48K | ▼ -161.96K | ▲ -63.00K | ▲ -1.22K | ▼ -19.00K |
Free Cash Flow | -10.99M | ▼ -17.10M | ▲ -14.60M | ▲ -12.16M | ▲ -9.24M | ▼ -11.91M | ▼ -16.71M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)